Feedback / Questions
SRP-001 - South Rampart Pharma
https://www.prnewswire.com/news-releases/south-rampart-pharma-successfully-completes-phase-1-study-and-expands-phase-2-plans-to-include-neuropathic-and-acute-pain-trials-302024129.html
Jan 2, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next